Zacks Research Issues Positive Estimate for THC Earnings

Tenet Healthcare Corporation (NYSE:THC) – Investment analysts at Zacks Research increased their Q1 2026 earnings per share (EPS) estimates for shares of Tenet Healthcare in a note issued to investors on Wednesday, February 25th. Zacks Research analyst Team now expects that the company will earn $4.14 per share for the quarter, up from their prior forecast of $3.73. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q2 2026 earnings at $4.10 EPS, FY2026 earnings at $16.76 EPS, Q3 2027 earnings at $4.01 EPS, Q4 2027 earnings at $3.28 EPS and FY2027 earnings at $16.35 EPS.

Several other equities research analysts have also weighed in on THC. KeyCorp raised their price objective on Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research note on Thursday, February 12th. UBS Group raised their target price on shares of Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Jefferies Financial Group boosted their price target on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. JPMorgan Chase & Co. raised their price objective on shares of Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Finally, Leerink Partners boosted their target price on shares of Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a research note on Friday, February 20th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $247.67.

Tenet Healthcare Price Performance

NYSE THC opened at $238.68 on Monday. Tenet Healthcare has a 12 month low of $109.82 and a 12 month high of $240.83. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The company’s 50 day simple moving average is $206.02 and its 200 day simple moving average is $200.15. The firm has a market capitalization of $20.76 billion, a PE ratio of 15.41, a P/E/G ratio of 1.18 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same quarter in the prior year, the firm posted $3.44 EPS. Tenet Healthcare’s revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS.

Hedge Funds Weigh In On Tenet Healthcare

Several hedge funds have recently made changes to their positions in the business. Triumph Capital Management bought a new stake in Tenet Healthcare during the third quarter worth $25,000. Activest Wealth Management bought a new stake in Tenet Healthcare during the fourth quarter worth about $26,000. Elyxium Wealth LLC acquired a new stake in shares of Tenet Healthcare in the 4th quarter valued at $29,000. William B. Walkup & Associates Inc. bought a new position in shares of Tenet Healthcare in the third quarter worth about $32,000. Finally, Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare during the 2nd quarter worth approximately $35,000. 95.44% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Nadja West sold 2,178 shares of the firm’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares in the company, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.81% of the company’s stock.

More Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Wall Street Zen upgraded THC to a “Strong‑Buy,” signaling fresh buy-side interest and likely supporting demand for the stock. Article Title
• Positive Sentiment: Zacks and other outlets have raised near‑term earnings estimates (Q1/Q2 FY2026 and FY2026), which supports the company’s earnings trajectory and provides backing for current valuation assumptions. Article Title
• Neutral Sentiment: A Yahoo Finance piece questions whether it’s too late to buy after an ~89% one‑year rally — this is market commentary on valuation and investor sentiment rather than new company fundamentals, and can amplify volatility as investors reassess upside. Article Title
• Negative Sentiment: Zacks’ detailed notes are mixed: while they raised FY2026 and some near‑term quarter forecasts, they trimmed several FY2027 and late‑year quarterly estimates (Q3/Q4 2027 and FY2027), indicating analyst caution about longer‑term growth and limiting upward re‑rating potential. Article Title

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.